Cartesian Therapeutics, Inc. (RNAC)

Cartesian Therapeutics Statistics

Total Valuation

RNAC has a market cap or net worth of $351.74 million. The enterprise value is $281.31 million.

Market Cap	351.74M
Enterprise Value	281.31M

Important Dates

The next estimated earnings date is Monday, November 11, 2024, before market open.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

RNAC has 21.38 million shares outstanding. The number of shares has increased by 67.57% in one year.

Shares Outstanding	21.38M
Shares Change (YoY)	+67.57%
Shares Change (QoQ)	+228.61%
Owned by Insiders (%)	49.87%
Owned by Institutions (%)	26.22%
Float	9.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.49
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.78

Current Ratio	4.78
Quick Ratio	4.70
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-28.43

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	$1.42M
Profits Per Employee	-$7.03M
Employee Count	38
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-19.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.95% in the last 52 weeks. The beta is 0.83, so RNAC's price volatility has been lower than the market average.

Beta (5Y)	0.83
52-Week Price Change	-48.95%
50-Day Moving Average	15.22
200-Day Moving Average	20.50
Relative Strength Index (RSI)	57.00
Average Volume (20 Days)	69,211

Short Selling Information

The latest short interest is 2.01 million, so 9.41% of the outstanding shares have been sold short.

Short Interest	2.01M
Short Previous Month	2.01M
Short % of Shares Out	9.41%
Short % of Float	20.80%
Short Ratio (days to cover)	22.60

Income Statement

In the last 12 months, RNAC had revenue of $54.10 million and -$267.20 million in losses. Loss per share was -$32.82.

Revenue	54.10M
Gross Profit	2.67M
Operating Income	-36.19M
Pretax Income	-248.65M
Net Income	-267.20M
EBITDA	-35.35M
EBIT	-36.19M
Loss Per Share	-$32.82

Balance Sheet

The company has $87.23 million in cash and $14.87 million in debt, giving a net cash position of $72.36 million or $3.38 per share.

Cash & Cash Equivalents	87.23M
Total Debt	14.87M
Net Cash	72.36M
Net Cash Per Share	$3.38
Equity (Book Value)	-101.46M
Book Value Per Share	-5.69
Working Capital	98.67M

Cash Flow

In the last 12 months, operating cash flow was -$62.86 million and capital expenditures -$2.25 million, giving a free cash flow of -$65.12 million.

Operating Cash Flow	-62.86M
Capital Expenditures	-2.25M
Free Cash Flow	-65.12M
FCF Per Share	-$3.05

Margins

Gross Margin	4.94%
Operating Margin	-66.89%
Pretax Margin	-459.59%
Profit Margin	n/a
EBITDA Margin	-65.34%
EBIT Margin	-66.89%
FCF Margin	-120.36%

Dividends & Yields

RNAC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-67.57%
Shareholder Yield	-67.57%
Earnings Yield	-75.55%
FCF Yield	-18.41%

Analyst Forecast

The average price target for RNAC is $41.60, which is 152.89% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$41.60
Price Target Difference	152.89%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	10.66%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on April 5, 2024. It was a reverse split with a ratio of 0.0333333:1.

Last Split Date	Apr 5, 2024
Split Type	Reverse
Split Ratio	0.0333333:1

Scores

RNAC has an Altman Z-Score of -2.18 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.18
Piotroski F-Score	1